Literature DB >> 26638766

Endocannabinoid Mechanisms Influencing Nausea.

Martin A Sticht1, Erin M Rock2, Cheryl L Limebeer2, Linda A Parker3.   

Abstract

One of the first recognized medical uses of Δ(9)-tetrahydrocannabinol was treatment of chemotherapy-induced nausea and vomiting. Although vomiting is well controlled with the currently available non-cannabinoid antiemetics, nausea continues to be a distressing side effect of chemotherapy and other disorders. Indeed, when nausea becomes conditionally elicited by the cues associated with chemotherapy treatment, known as anticipatory nausea (AN), currently available antiemetics are largely ineffective. Considerable evidence demonstrates that the endocannabinoid system regulates nausea in humans and other animals. In this review, we describe recent evidence suggesting that cannabinoids and manipulations that enhance the functioning of the natural endocannabinoid system are promising treatments for both acute nausea and AN.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Arachidonoylglycerol; Acute nausea; Anandamide; Anticipatory nausea; CB1; Endocannabinoid; Gaping; Illness

Mesh:

Substances:

Year:  2015        PMID: 26638766     DOI: 10.1016/bs.irn.2015.09.001

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  5 in total

Review 1.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

2.  Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB1 receptors.

Authors:  Erin M Rock; Guillermo Moreno-Sanz; Cheryl L Limebeer; Gavin N Petrie; Roberto Angelini; Daniele Piomelli; Linda A Parker
Journal:  Br J Pharmacol       Date:  2017-09-20       Impact factor: 8.739

Review 3.  The Role of the Endocannabinoid System in the Brain-Gut Axis.

Authors:  Keith A Sharkey; John W Wiley
Journal:  Gastroenterology       Date:  2016-04-29       Impact factor: 22.682

4.  The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.

Authors:  Molly S Crowe; Catheryn D Wilson; Emma Leishman; Paul L Prather; Heather B Bradshaw; Matthew L Banks; Steven G Kinsey
Journal:  Br J Pharmacol       Date:  2017-11-20       Impact factor: 8.739

5.  Aerobic exercise reduces anxiety and fear ratings to threat and increases circulating endocannabinoids in women with and without PTSD.

Authors:  Kevin M Crombie; Josh M Cisler; Cecilia J Hillard; Kelli F Koltyn
Journal:  Ment Health Phys Act       Date:  2020-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.